RPAM
Rhenman & Partners Asset Management’s BioNTech BNTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.82M | Buy |
35,870
+120
| +0.3% | +$12.8K | 0.48% | 59 |
|
2025
Q1 | $3.26M | Sell |
35,750
-17,000
| -32% | -$1.55M | 0.37% | 57 |
|
2024
Q4 | $6.01M | Buy |
52,750
+1,750
| +3% | +$199K | 0.62% | 50 |
|
2024
Q3 | $6.06M | Buy |
+51,000
| New | +$6.06M | 0.49% | 61 |
|
2023
Q4 | – | Sell |
-53,000
| Closed | -$5.76M | – | 88 |
|
2023
Q3 | $5.76M | Sell |
53,000
-17,000
| -24% | -$1.85M | 0.62% | 47 |
|
2023
Q2 | $7.56M | Sell |
70,000
-22,000
| -24% | -$2.37M | 0.8% | 42 |
|
2023
Q1 | $11.3M | Sell |
92,000
-17,000
| -16% | -$2.08M | 1.24% | 30 |
|
2022
Q4 | $16.4M | Buy |
109,000
+10,000
| +10% | +$1.5M | 1.71% | 23 |
|
2022
Q3 | $13.6M | Buy |
99,000
+9,000
| +10% | +$1.24M | 1.43% | 27 |
|
2022
Q2 | $13.4M | Buy |
90,000
+5,000
| +6% | +$746K | 1.52% | 26 |
|
2022
Q1 | $14.5M | Buy |
+85,000
| New | +$14.5M | 1.43% | 29 |
|